David J. Arthur - Net Worth and Insider Trading

David J. Arthur Net Worth

The estimated net worth of David J. Arthur is at least $17,553 dollars as of 2024-05-21. David J. Arthur is the CEO of Salarius Pharmaceuticals Inc and owns about 35,121 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $17,553. Details can be seen in David J. Arthur's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David J. Arthur has not made any transactions after 2022-05-26 and currently still holds the listed stock(s).

Transaction Summary of David J. Arthur

To

David J. Arthur Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David J. Arthur owns 1 companies in total, including Salarius Pharmaceuticals Inc (SLRX) .

Click here to see the complete history of David J. Arthur’s form 4 insider trades.

Insider Ownership Summary of David J. Arthur

Ticker Comapny Transaction Date Type of Owner
SLRX Salarius Pharmaceuticals Inc 2022-05-26 director & Chief Executive Officer

David J. Arthur Latest Holdings Summary

David J. Arthur currently owns a total of 1 stock. David J. Arthur owns 35,121 shares of Salarius Pharmaceuticals Inc (SLRX) as of May 26, 2022, with a value of $17,553.

Latest Holdings of David J. Arthur

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SLRX Salarius Pharmaceuticals Inc 2022-05-26 35,121 0.50 17,553

Holding Weightings of David J. Arthur


David J. Arthur Form 4 Trading Tracker

According to the SEC Form 4 filings, David J. Arthur has made a total of 5 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 1,756 shares on May 26, 2022, which cost David J. Arthur around $7,902.

Insider Trading History of David J. Arthur

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David J. Arthur Trading Performance

GuruFocus tracks the stock performance after each of David J. Arthur's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David J. Arthur is -12.69%. GuruFocus also compares David J. Arthur's trading performance to market benchmark return within the same time period. The performance of stocks bought by David J. Arthur within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David J. Arthur's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David J. Arthur

Average Return

Average return per transaction

Outperforming Transactions

1 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.38
Relative Return to S&P 500(%) 5.33

David J. Arthur Ownership Network

Ownership Network List of David J. Arthur

No Data

Ownership Network Relation of David J. Arthur


David J. Arthur Owned Company Details

What does Salarius Pharmaceuticals Inc do?

Who are the key executives at Salarius Pharmaceuticals Inc?

David J. Arthur is the director & Chief Executive Officer of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , Chief Financial Officer Scott Jordan , and Controller Pao-yu Chuang .

Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Salarius Pharmaceuticals Inc Insider Transactions

No Available Data

David J. Arthur Mailing Address

Above is the net worth, insider trading, and ownership report for David J. Arthur. You might contact David J. Arthur via mailing address: 2450 Holcome Blvd., Suite J-608, Houston Tx 77021.

Discussions on David J. Arthur

No discussions yet.